Evaluation of Tonabersat for DME (NCT05727891)

🧪 Interventions in This Study

• Tonabersat (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (28 Sites)

Showing the first 25 of 28 sites.

• Retina Associates of Southern California — Huntington Beach, California
• Loma Linda University — Loma Linda, California
• East Bay Retina Consultants, Inc. — Oakland, California
• Southern California Desert Retina Consultants, Inc. — Palm Desert, California
• Macula Retina Vitreous Institute — Torrance, California
• National Ophthalmic Research Institute — Fort Myers, Florida
• University of Florida- Jacksonville — Jacksonville, Florida
• Central Florida Retina Institute — Lakeland, Florida
• Florida Retina Consultants — Lakeland, Florida
• Southeast Eye Institute, P.A. dba Eye Associates of Pinellas — Pinellas Park, Florida
• Southeast Retina Center — Augusta, Georgia
• Thomas Eye Group — Sandy Springs, Georgia
• Illinois Retina Associates — Oak Park, Illinois
• Midwest Eye Institute — Indianapolis, Indiana
• Joseph E. Humble and Raymond Haik PTRS DBA Eye Assoc of Northeast Louisiana — West Monroe, Louisiana
• Elman Retina Group — Baltimore, Maryland
• Boston Medical Center Corporation — Boston, Massachusetts
• Joslin Diabetes Center — Boston, Massachusetts
• Mayo Clinic — Rochester, Minnesota
• Retina Research Institute, LLC — St Louis, Missouri
• Retina-Vitreous Surgeons of Central NY, PC — Liverpool, New York
• Verum Research LLC — Eugene, Oregon
• The Trustees of the University of Pennsylvania — Philadelphia, Pennsylvania
• Pittsburg Clinical Trial Consortium — Sewickley, Pennsylvania
• Hilton Head Retina Institute — Hilton Head Island, South Carolina

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diabetic Macular Edema

• Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT) — Beverly Hills, California
• 4D-150 in Patients With Diabetic Macular Edema — Hagerstown, Maryland
• Mean Visual Acuity Changes Following Five Injections of Aflibercept — Hamilton, Ontario
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) — Mesa, Arizona
• A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema — Phoenix, Arizona
• A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME — Mesa, Arizona

Explore by condition: All Diabetic Macular Edema clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.